A carregar...
Competition and price among brand-name drugs in the same class: A systematic review of the evidence
BACKGROUND: Some experts have proposed combating rising drug prices by promoting brand–brand competition, a situation that is supposed to arise when multiple US Food and Drug Administration (FDA)-approved brand-name products in the same class are indicated for the same condition. However, numerous r...
Na minha lista:
| Publicado no: | PLoS Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6667132/ https://ncbi.nlm.nih.gov/pubmed/31361747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1002872 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|